Filing Details
- Accession Number:
- 0001683168-24-000329
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2024-01-17 16:03:11
- Reporting Period:
- 2024-01-10
- Accepted Time:
- 2024-01-17 16:03:11
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1759186 | Coeptis Therapeutics Holdings Inc. | COEP | Biological Products, (No Disgnostic Substances) (2836) | 981465952 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 2008384 | Brian Cogley | 105 Bradford Road Suite 420 Wexford PA 15090 | Chief Financial Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2024-01-10 | 5,000 | $0.67 | 30,000 | No | 4 | P | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | P | Direct |
Footnotes
- Includes 25,000 shares of common stock that are issuable upon exercise of options that are or will become exercisable in the next 60 days.
Billionaire Hedge Funds
